Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: Does the choice of biological therapy matter?

Ulf Lindström, Karin Bengtsson, Tor Olofsson, Daniela Di Giuseppe, Bente Glintborg, Helena Forsblad-D'elia, Lennart T.H. Jacobsson, Johan Askling

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: Does the choice of biological therapy matter?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds